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A B C D E F G H I J K
NEED STRATEGIC PRIORITY MARKET FAILURE Provide targeted grant or 
loan funding towards 
specialist equipment
Increase the scope and 
support offered by 
Germinator/Biobator 
Programmes
Take the lead in ensuring 
accommodation is 
coordinated across region 
and needs are met
Provide an integrated 
regional  Network for  LHT 
Knowledge Exchange 
Transform HEI business 
interaction through the 
appointment of deep 
sector specialist brokers 
that act across the entire 
research base
Drive the development of a 
major research facility 
within the region that will 
benefit business and 
academia alike
Improve access to 
European and national 
funding through a 
dedicated scheme
Lead and coordinate 
specialist business support 
infrastructure
Continuation of the 
regulatory affairs, clinical 
evaluation and NHS 
procurement networks
Life Science and Health 
Technology (LHT) specific 
training
Targeted support for 
overseas missions
OWNER BioCity BioCity BioCity bioKneX bioKneX BioKnex Medilink / Pera Medilink Medilink / NHS Inn. Hub Medilink UKTI/Medilink
Knowledge of the regulatory 
environment
Support companies to overcome 
the regulatory barriers 
SMEs have difficulties 
understanding and negotiating 
regulatory barriers
Medilink Integrate regulatory training 
offerings into 
Germinator/Biobator 
programme
Link to regional & national 
initiatives
Guidance on regulations
Access to specialists
Training in European & US 
regulations & legislation, 
quality systems, staff roles, 
system operation, other 
specialist roles
Guidance service for 
appropriate international 
regulations
Knowledge of global healthcare 
markets
Facilitate access to the global 
market place 
Difficulty in accessing global 
healthcare markets
UKTI Provide market and 
technology information to 
support funding 
applications
Provide support that 
encourages SMEs to 
innovate in their 
approaches to markets:
Facilitate access routes 
into health services.
Establish strategic 
relationships with 
international quangos.
Help SMEs develop shared 
sales forces with other 
SMEs.
Supply chain events.
Guidance on regulations
Identification of NHS 
contacts, contracts, tenders 
& support with bids
Provide mechanism for 
assessment of health 
economics and technology 
for new ideas from a 
clinical, industrial and 
academic perspective
Provide market and 
procurement training
50% company subsidy for 
N. America / W. Europe 
focused support not 
covered by current UKTI 
policy.
1) Improve knowledge flow 
between organisations;
2) Increase inter-organisation 
trade;
3) Helps create and embed an 
entrepreneurial and innovative 
culture
Engineer sub-regional cluster 
growth to create a better 
environment for innovation
A self sustaining critical mass of 
businesses has not yet developed 
and so intervention is required to 
engineer this.
BioCity Target grants/loans to 
identified "hot spots"
Use Germinator/Biobator to 
increase the number & 
quality of innovation led 
companies within the "hot 
spots"and accelerate their 
initial development
Ensure accommodation 
for new & existing 
innovative companies is 
within identified hot spots
Target knowledge 
exchange activties to 
identified "hot spots"
Locate facility within one of 
the targeted hot spots
Link funding with 
development of centres of 
excellence where 
appropriate. 
Use EU funding to secure 
international supply chains 
for regional healthcare 
businesses.
Ensure support can be 
accessed from all "hot 
spot" locations
Target the provision of 
training into identified "hot-
spots"
Use "Hot spots" to 
disseminate information
Improved product and process 
development through high quality 
provision of support with greater 
simplification and better strategic 
coordination
Coordinate the provision of 
specialist business support 
Underperformance in new product 
and process development.
Low adoption of innovation & under 
investment in research by SMEs
Medilink Use funding route to 
communicate available 
business support.
Germinator/Biobater will be 
one route by which 
specialist business support 
is accessed
Ensure accommodation is 
linked with business 
support outposts
Ensure knowledge 
exchange is integrated 
into wider business 
support and that both can 
be accessed from each 
other as a point of entry.
Provide access to HEI IP 
and process development 
capabilities. 
Increase access by SMEs 
to HEI infrastructure.
Ensure support 
appropriately linked
Ensure support is 
appropriately linked to 
other initiatives. 
LHT specialist to link 
companies with support 
provision including 
Business Link.
Provide support for 
healthcare product and 
process development via 
MAS+ programme
Support Business 
Intelligence on market size 
and value for innovative 
new product and process 
development.
Guidance & updates.
Ensure regulations are 
considered throughout 
product development
Product testing, clinical 
evaluation, & clinical trials 
Ensure support 
appropriately linked
Facilities appropriate to a 
company's stage of development
Coordination and development of 
accommodation and facilities.
The sector is not sufficiently well 
developed for private enterprise to 
be attractive to private enterprise to 
fill the gaps in the accomodation 
ladder. Neither will it look sufficiently 
far ahead to address future facilities 
needs.
BioCity Liaise with all agencies 
involved in developing 
strategic plans for sub 
regions. Ensure overall 
regional plan is developed
Provide access to HEI 
facilities, services and 
consultancy to address 
differing needs of SMEs. 
Provide input into 
company research needs 
to help plan future 
provision.
Coordinate with the 
development of other 
research-based facilities. 
Lead identifying the 
opportunity, raising funding 
and ultimate creation of 
facility.
Ensure that access to 
support is included where 
facilities are developed.
To take advantage of market 
opportunities 
Support companies to access high 
level business intelligence 
A failure to read market 
opportunities and market trends
Medilink Germinator/Biobator will be 
one route by which high 
level business intelligance 
is accessed.
Use business intelligence 
capabilities to suport 
companies in decision 
making with regard to 
knowledge transfer.
Maintain pool of specialist 
mentors & advisors.
Use business intelligence 
services including 
Globalwatch and Pera 
technology promoters to 
support exploitation of 
future market 
opportunities.
Provision of regulation 
updates & changes
Provision of NHS market 
intelligence
To raise the profile of the East 
Midlands Life & Health 
Technologies ( EM LHT) industrial 
& academic activities and thereby 
benefit local companies through 
improved recruitment, fundraising 
and revenue generating 
opportunities.
Coordinate and create a regional 
communication and marketing 
plan for EM LHT. 
No current coordinated regional 
brand for EM LHT leading to diffuse 
and ineffective message. Loss of 
opportunities to more established 
regions
bioKneX or
Medilink
(tbc)
Germinator/Biobater will be 
promoted in a coordinated 
way with other sector 
activities and will use 
common messages.
Ensure accomodation 
sites act as access points 
for delivery of message.
Ensure that all groups 
across the sector receive 
a consistant message 
use novel deep sector 
specialist approach to 
highlight activities in the 
region. 
Shout about regions 
successes
Ensure the chosen 
opportunity fits with the 
overall message on 
strengths in the region. 
Ensure development of the 
facility is fully exploited for 
marketing purposes.
Communication of what's 
available
Communicate the market 
to high net worth 
individuals outside the 
region
Promote all sector-related  
training activities in a 
coordinated way. Single 
point of information for 
everything that's going on.
To make best use of the regional 
science base 
Promote exploitation of 
Technology and Know-How
A failure to leverage the science 
base
Difficulty accessing support from 
HEIs
bioKneX Target funding to support 
HEI-business interaction
 Utilise knowledge 
exchange brokerage for 
Business- HEI interaction. 
Provide Innovation portal 
to increase frequency of 
HEI-SME collaboration
Use specialist brokers to 
Coordinate business HEI 
interaction to increase 
number of collaborations 
and access to EM 
knowledge base.
Integrate Academic and 
Industrial research within 
same facility. Economies of 
scale and increased 
synergy 
Use business support 
infrastructure to direct 
companies towards 
specialist support for 
access to new 
technologies.
Liaison with NHS & 
companies to facilitate 
access
Intellectual property 
management
Life science & healthcare 
entrepreneur action learning 
development programme
Sufficient levels of appropriately 
skilled and qualified personnel 
(repatriation and training) 
Build a high level skills base for 
the region (LHT skills – Life and 
Health Technologies) 
A lack of appropriately skilled and 
qualified personnel (repatriation and 
training) 
bioKneX Use Germinator to bring in 
management talent from 
outside the region
Map current and future 
regional skill gaps, define 
emerging technology 
needs and match with 
regional and national 
training provision. 
Increase regional industry 
experience pool. 
Use the facility to build on 
skills strengths in the region 
and contribute to 
addressing future needs.
Use company interactions 
to understand business 
training needs and feed 
into programme 
development
Consider regulatory training 
needs and incorporate into 
programme as necessary.
Lead the developmnent of a 
coordinated training 
programme that addresses 
priority needs in the sector 
(e.g. entrepreneurial 
development)
An understanding of available 
funding sources, how to deliver 
value on existing funding and how 
to make the business case for 
next round of funding
Increase access to and take up of 
funding for business growth and 
development 
A failure to access and use the 
available funding for innovation and 
lack of specialist funding sources
BioCity 50% loan/grant towards 
equipment (max £50k). 
Easy to access.
Use Germinator as one of 
the routes to access 
training in investment 
readiness.
Increase access to 
funding for collaborative 
R&D. Coordinate 
innovation funding to 
maximise ROI.
Use facility to draw in 
further funding for 
academic/business 
collaboration.
Provide access to expert 
organisations and 
personnel to support 
regional, national and EU 
R&D funds for innovative 
product and process 
development. 
Ensure companies are 
adequately informed of 
available funding 
opportunities. Link with 
existing schemes.
Link in with existing 
programmes, such as 
Connect InvoRed, to ensure 
sector specialist needs are 
met and supplement where 
necessary.
MEASURABLE OUTPUTS 10 companies supported 
each year
8 companies passing 
through Germinator each 
year. Companies through 
Biobater
Coordinating individual in 
place and recognised as 
such.
Single reference source 
for all property-related 
activities in the region 
affecting LHT.
Regional R&D database 
completed. Increase 
network membership to 
1000 registered 
members. Provide access 
to all EM LHT business 
and HEIs
Additional hires in place. 
Increased flow of SME 
collaboration opportunites 
to HEIs demonstrated. 
New hire in post. 
Stakeholder engagement 
complete. Outline plans 
developed. 
10 companies supported 
each year
40-50 companies 
supported each year
30 companies supported 
each year.
120 people receiving training 
per year
30-50 companies 
supported per year
DELIVERED USING: Use Grants to transform a 
business, SFIE, R&D 
grants etc.iNet NTI 
equipment grant
Link to generic start-up and 
early growth products and 
support only where it adds 
value to generic offering
Part of iNet adviser role. 
Brings in match funding 
from BioCity.
Part of iNet adviser role. 
Cements iNet with 
bioKnex, because this is a 
collaboratively funded and 
delivered activity
Part of iNet adviser role 
as sector specialist 
broker. Description of 
tactical intervention needs 
clarifying.
Part of iNet adviser role Support Part of iNet adviser role 
with some event delivery
Part of iNet adviser role. 
Break budget down into 
Scout maintenance and 
regulatory advice from iNet 
adviser, and other non-core 
iNet funding.
IDB is part of iNet adviser 
role. Delivery should be 
linked to wider provision 
wherever possible
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